Your browser doesn't support javascript.
loading
Ethics review of COVID-19 human challenge studies: A joint HRA/WHO workshop.
Williams, Eloise; Craig, Kathrine; Chiu, Christopher; Davies, Hugh; Ellis, Stephanie; Emerson, Claudia; Jamrozik, Euzebiusz; Jefford, Monica; Kang, Gagandeep; Kapulu, Melissa; Kolstoe, Simon E; Littler, Katherine; Lockett, Anthony; Messer, Janet; McShane, Helen; Saenz, Carla; Selgelid, Michael J; Shah, Seema; Smith, Peter G; Yamazaki, Naho.
  • Williams E; Department of Microbiology, Royal Melbourne Hospital, Melbourne, Victoria, Australia; Department of Microbiology and Immunology, University of Melbourne at the Peter Doherty Institute, Melbourne, Victoria, Australia. Electronic address: eloise.williams@mh.org.au.
  • Craig K; Specialist Ad-Hoc Research Ethics Committee for COVID-19 Human Challenge Studies, Health Research Authority, London, UK.
  • Chiu C; Department of Infectious Disease, Imperial College London, London, UK.
  • Davies H; Specialist Ad-Hoc Research Ethics Committee for COVID-19 Human Challenge Studies, Health Research Authority, London, UK.
  • Ellis S; Specialist Ad-Hoc Research Ethics Committee for COVID-19 Human Challenge Studies, Health Research Authority, London, UK.
  • Emerson C; Institute on Ethics & Policy for Innovation, Department of Philosophy, McMaster University, Hamilton, Ontario, Canada.
  • Jamrozik E; The Ethox Centre & Wellcome Centre for Ethics and the Humanities, Nuffield Department of Population Health, University of Oxford, Oxford, Oxfordshire, UK; Monash Bioethics Centre, Monash University, Clayton, Victoria, Australia; Royal Melbourne Hospital Department of Medicine, University of Melb
  • Jefford M; Specialist Ad-Hoc Research Ethics Committee for COVID-19 Human Challenge Studies, Health Research Authority, London, UK.
  • Kang G; The Wellcome Trust Research Laboratory, Division of Gastrointestinal Sciences, Christian Medical College, Vellore, India.
  • Kapulu M; KEMRI-Wellcome Trust Research Programme, Centre for Geographic Medicine Research-Coast, Kilifi, Kenya; Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
  • Kolstoe SE; Specialist Ad-Hoc Research Ethics Committee for COVID-19 Human Challenge Studies, Health Research Authority, London, UK; School of Health & Care Professions, University of Portsmouth, Portsmouth, UK.
  • Littler K; Global Health Ethics Unit, World Health Organization, Geneva, Switzerland.
  • Lockett A; Specialist Ad-Hoc Research Ethics Committee for COVID-19 Human Challenge Studies, Health Research Authority, London, UK; King's College London, London, UK.
  • Elena Rey; Centro Internacional de Entrenamiento e Investigaciones Médicas - CIDEIM, Cali, Colombia; Universidad Icesi, Cali, Colombia.
  • Messer J; Health Research Authority, London, UK.
  • McShane H; Department of Paediatrics, University of Oxford, Oxford, UK.
  • Saenz C; Regional Program on Bioethics, Department of Health Systems and Services, Pan American Health Organization, Washington D.C., USA.
  • Selgelid MJ; Institute on Ethics & Policy for Innovation, Department of Philosophy, McMaster University, Hamilton, Ontario, Canada.
  • Shah S; Lurie Children's Hospital & Northwestern University Feinberg School of Medicine, Chicago, USA.
  • Smith PG; MRC International Statistics and Epidemiology Group, London School of Hygiene and Tropical Medicine, London, UK.
  • Yamazaki N; Health Research Authority, London, UK.
Vaccine ; 40(26): 3484-3489, 2022 06 09.
Article en En | MEDLINE | ID: mdl-35210119

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Revisión Ética / COVID-19 Tipo de estudio: Guideline Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Revisión Ética / COVID-19 Tipo de estudio: Guideline Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article